| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2768086A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2767285A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 02/03/2011 | CA2767066A1 Pyridine and pyrazine derivatives as protein kinase modulators |
| 02/03/2011 | CA2766367A1 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | CA2763628A1 Tricyclic inhibitors of jak |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280011A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2 |
| 02/02/2011 | EP2279777A2 Compounds and compositions as channel activating protease inhibitors |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2279741A2 Caprolactams and their use as anti-inflammatory agents |
| 02/02/2011 | EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents |
| 02/02/2011 | EP2279735A2 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 02/02/2011 | EP2279196A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/02/2011 | EP2279030A2 Method of modulating t cell-dependent immune responses |
| 02/02/2011 | EP2279003A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 02/02/2011 | EP2279001A1 Inhibitors of gm-csf and il-17 for therapy |
| 02/02/2011 | EP2278981A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 02/02/2011 | EP2278979A2 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 02/02/2011 | EP2278947A1 Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs |
| 02/02/2011 | EP1606265B1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/02/2011 | EP1567508B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/02/2011 | CN1965836B Oral solid formulation and its preparation method |
| 02/02/2011 | CN101962384A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/02/2011 | CN101962349A 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof |
| 02/02/2011 | CN101961497A Inhibition of Syk kinase expression |
| 02/02/2011 | CN101961479A Chinese medicinal composition for treating bellyache and preparation method thereof |
| 02/02/2011 | CN101961478A Medicament for treating hyperosteogeny, rheumatism and rheumatoid diseases and preparation method thereof |
| 02/02/2011 | CN101961477A Rheumatic bone ache medicine |
| 02/02/2011 | CN101961467A Medicine for treating knee osteoarthritis and preparation method and application thereof |
| 02/02/2011 | CN101961443A Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof |
| 02/02/2011 | CN101961435A Rheumatism ostalgia plaster |
| 02/02/2011 | CN101961434A Rheumatic Xintong powder |
| 02/02/2011 | CN101961418A Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch |
| 02/02/2011 | CN101961417A Preparation method of tablet for curing laryngalgia |
| 02/02/2011 | CN101961408A Method for measuring murrayone content of iculatae medicinal material |
| 02/02/2011 | CN101961406A Medicament for treating muscle and bone diseases causes by chronic infectious arthritis |
| 02/02/2011 | CN101961400A Chinese medicament for treating sciatica and preparation method and application thereof |
| 02/02/2011 | CN101961389A Scorpion pain-relieving powder medicine |
| 02/02/2011 | CN101961384A Method for extracting baical skullcap root flavonoids fractions |
| 02/02/2011 | CN101961381A Preparation method of particles in formula of salvia miltiorrhiza bunge and quality detection method thereof |
| 02/02/2011 | CN101961376A Method for refining sweet basil herb extract |
| 02/02/2011 | CN101961371A Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 02/02/2011 | CN101961370A Method for grinding resin medicinal materials and application |
| 02/02/2011 | CN101961366A Preparation method of malan straw extract, malan straw product, pharmaceutical composition and application thereof |
| 02/02/2011 | CN101961331A Ubiquitin E1 inhibitor and preparation method thereof |
| 02/02/2011 | CN101961323A Self-emulsified resveratrol soft capsules |
| 02/02/2011 | CN101961318A Lappaconitine sustained release microspheres for injection and preparation method thereof |
| 02/02/2011 | CN101961288A Leaf-like Chinese medicinal powder-combined portable massager |
| 02/02/2011 | CN101961149A Special function nano-element Chinese medicinal water emergency fabric body-building clothes |
| 02/02/2011 | CN101623387B Pill for treating traumatic injury, new and old fracture and lumbar muscle strain |
| 02/02/2011 | CN101574456B Blood circulation and channel invigorating soup |
| 02/02/2011 | CN101380375B External traditional Chinese medicine preparation for treating bone and soft tissue injury and preparation method thereof |
| 02/02/2011 | CN101326945B Jujube chestnut leaf tea |
| 02/02/2011 | CN101317996B Traditional Chinese medicine emplastrum for rheumatism of muscles and bones |
| 02/02/2011 | CN101297896B Method for extracting antipyretic and detoxicated oral liquid using cellulase |
| 02/02/2011 | CN101291671B Liquid preparation for external application containing indomethacin |
| 02/02/2011 | CN101273970B Microemulsion type preparation of glucocorticoid medicine for nasal cavity |
| 02/02/2011 | CN101143166B Medicine for swelling and relieving pain and its preparation method and application |
| 02/02/2011 | CN101129354B Pharmaceutical composition containing triacetyl andrographolidume and medical use of the same |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879901 Sublingual Formulations of Ketorolac or Salts Thereof |
| 02/01/2011 | US7879899 Injectable veterinary composition for small animals |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879843 Benzothiazin-3-one compound and intermediate therefor |
| 02/01/2011 | US7879817 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879373 comprises curcuminoid and an essential oil of turmeric; curcuminoid mixture consists of curcumin, demethoxycurcumin and bisdemethoxycurcumin and essential oil of turmeric comprises about 45% ar-turmerone |
| 02/01/2011 | US7879366 Halogenated composition, method for preparing same and uses thereof |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2558429C Compositions and methods for preventing or treating an inflammatory response |
| 02/01/2011 | CA2502633C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 02/01/2011 | CA2481468C Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2451206C Urea derivatives with antiproteolytic activity |
| 02/01/2011 | CA2447878C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 02/01/2011 | CA2446812C Novel sulfonate-substituted pyrazolopyridine derivatives |
| 02/01/2011 | CA2425172C Methods of decreasing or preventing pain using spicamycin derivatives |
| 02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/01/2011 | CA2369560C Agent for prophylaxis and treatment of liver disease |
| 02/01/2011 | CA2342133C Ophthalmic formulations |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |